Svih 75 vakcinisanih u Gerontološkom centru Novi Pazar dobrog su stanja bez ikakvih kontraindikacija

epa04476032 A NGO volunteer receives a dose of experimental vaccine 'cAd3-EBOZ Lau' from a nurse at the Lausanne University Hospital (CHUV) in Lausanne, Switzerland, 04 November 2014. Swissmedic approved the application for a trial with an experimental Ebola vaccine at the Lausanne University Hospital (CHUV). It will be conducted on 120 volunteer participants. The trial continues the series that began in the USA, the UK and Mali. The vaccine, based on a genetically modified chimpanzee adenovirus will initially be administered to healthy volunteers who will be deployed as medical staff in the fight against the Ebola epidemic in West Africa. EPA/JEAN-CHRISTOPHE BOTT